Dalradian Resources Inc.
TSX : DNA
TSX : DNA.WT

Dalradian Resources Inc.

December 02, 2010 09:29 ET

Dalradian Intercepts 1.83 Metres of 37.41 g/t of Gold at Tyrone Project

TORONTO, ONTARIO--(Marketwire - Dec. 2, 2010) - Dalradian Resources Inc. ("Dalradian" or the "Company") (TSX:DNA)(TSX:DNA.WT) has successfully extended a high grade zone in the T17 vein 85 metres vertically below the exploration adit at its Curraghinalt gold deposit in Northern Ireland. Infill hole 10-CT-73 intercepted a true width of 1.83 metres grading 37.41 g/t gold. In addition, further drill holes targeting the Bend and Crow veins have intercepted true widths of 1.52 metres grading 27.05 g/t gold and 0.51 metres grading 18.66 g/t gold respectively. Neither the Bend nor the Crow, referred to in Dalradian's News Release No. 6 dated October 14, 2010, are included in the NI 43-101 technical report dated May 10, 2010. A map and tables of the assay results for nine drill holes are appended to this release, which may be viewed at Dalradian's newly launched website, www.dalradian.com.

"These results demonstrate the presence of more high grade mineralization associated with the T17 vein that we intend to follow to depth," said Patrick F. N. Anderson, Dalradian's chairman and chief executive officer. "Moreover, results from the Bend and the Crow veins illustrate the potential to find new mineralized veins not included in the existing resource estimate."

The full list of vein composites are tabulated in the tables appended to this release. Omac Laboratories Ltd. (ISO/IEC 17025 accredited) of Loughrea, Republic of Ireland, performed the assays.

Qualified Person

Vaughan Williams, P. Geo, Eur. Geol., Project Manager, Aurum Exploration Services, a consultant to the Company, is the Qualified Person who supervised the preparation of the technical data in this news release.

Dalradian Resources Inc.: A golden opportunity in Northern Ireland

Dalradian is a Canadian-based exploration company working to increase its gold resources at its approximately 84,000-hectare Tyrone Project, which encompasses its flagship Curraghinalt mesothermal gold deposit, in counties Tyrone and Londonderry in Northern Ireland. Dalradian's NI 43-101 report, "A Mineral Resource Estimate for the Curraghinalt Gold Deposit and a Review of a Proposed Exploration Program for the Tyrone Project, County Tyrone and County Londonderry, Northern Ireland" is dated May 10, 2010 and prepared by Micon International Limited. Dalradian's common shares and warrants are listed on the Toronto Stock Exchange under the symbols DNA and DNA.WT respectively. For further information, please see the Company's website at www.dalradian.com.

Cautionary statement regarding forward-looking information

This news release includes certain information that may constitute "forward-looking information" under applicable Canadian securities legislation. Forward-looking information includes, but is not limited to, statements about strategic plans, spending commitments, future operations, results of exploration, future work programs, capital expenditures and objectives. Forward-looking information is necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results (including mineralization) and future events to differ materially from those expressed or implied by such forward-looking information, including the risks identified in the Company's prospectus under the heading "Risk Factors." There can be no assurance that such information will prove to be accurate, as actual results (including mineralization) and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information. All forward-looking information contained in this news release is given as of the date hereof and is based upon the opinions and estimates of management and information available to management as at the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

To view the appendices to this release, please visit the following link: http://media3.marketwire.com/docs/dnaFigs1202b.pdf.

Contact Information